Research advances in cytokines in the treatment of chronic hepatitis B
10.3969/j.issn.1001-5256.2022.08.002
- VernacularTitle:细胞因子在慢性乙型肝炎治疗中的研究进展
- Author:
Zixiang GAO
1
;
Zhongliang SHEN
1
,
2
;
Jing LIU
1
,
3
;
Youhua XIE
1
,
4
Author Information
1. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
2. Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China
3. Institutes of Biomedical Sciences, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
4. Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China
- Publication Type:Discussions by Experts
- Keywords:
Hepatitis B Virus;
Cytokines;
Hepatitis B, Chronic;
Therapeutics
- From:
Journal of Clinical Hepatology
2022;38(8):1710-1715
- CountryChina
- Language:Chinese
-
Abstract:
At present, there are still about 250 million people with chronic hepatitis B virus (HBV) infection around the world, which seriously threatens human life and health. Chronic hepatitis B (CHB) can develop into liver diseases such as liver fibrosis, liver cirrhosis, and hepatocellular carcinoma; however, there is still a limited number of antiviral drugs and an extremely low cure rate in clinical practice, and thus it is urgent to develop new antiviral drugs. HBV has strong hepatotropism and only infects a few primates such as humans and chimpanzees under natural conditions. Whether immune response (innate immunity and adaptive immunity) can effectively recognize and eliminate or inhibit HBV is an important factor leading to different outcomes after virus infection, and cytokines play an important immunoregulatory role in this process. This article summarizes and discusses the research advances in some key cytokines in CHB infection and treatment.
